Area of research
Epidemiology · Neurology
Research interest
Research interests include Medicine, REM sleep behavior disorder, Restless legs syndrome, Dementia with Lewy bodies, Disease, and Biology.
Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction
Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group
We need to do better: A systematic review and meta-analysis of diagnostic test accuracy of restless legs syndrome screening instruments
Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the <i>TRANK1</i> gene loci
Dopamine transporter imaging predicts clinically‐defined <i>α</i>‐synucleinopathy in REM sleep behavior disorder
SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
Comorbidities, treatment, and pathophysiology in restless legs syndrome
Treatment of restless legs syndrome: Evidence‐based review and implications for clinical practice (Revised 2017)<sup>§</sup>
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale – The sIRLS
Idiopathic REM sleep behaviour disorder and neurodegeneration — an update
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis
Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease
Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation
World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)
The European Narcolepsy Network (<scp>EU</scp>‐<scp>NN</scp>) database
The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial